Montpellier, France, November 17, 2015 – MEDTECH (Euronext, FR0010892950 – ROSA), a company specialized in designing, developing and marketing surgical robots, has once again been honored by Deloitte In Extenso at the 15th Annual Technology Fast 50 Awards for the Mediterranean Area.
Medtech received an award from Technology Fast 50's regional jury in the “Listed Company” category for its excellent performance in the growth and development of innovative technology in the field of minimally invasive neurosurgery.
Medtech distinguished itself by displaying a strong progression in its activities with an increase of +158% between 2014 and June 30, 2015. As of September 30, 2015, the Company has sold 51 ROSA™ robots worldwide and more than 2,600 procedures have been performed.
Medtech previously received the “Revelation” prize in the Technology Fast 50 Awards for the Mediterranean Area in 2014.
Upcoming venues and investors' meetings
- Stifel 2015 Healthcare Conference, New York November 17-18,2015
- Natixis Midcap Conference, ParisNovember 24, 2015
- Oddo Midcap Conference, LyonJanuary 7-8, 2016
Founded in 2002 by Bertin NAHUM and based near Montpellier, MEDTECH is a European specialist in the design, development and marketing of innovative robotic appliances to assist surgeons during their medico-surgical interventions, thus contributing to the implementation of safer, more efficient, less-invasive treatment.
In 2007, MEDTECH developed ROSA™, an innovative technological device devoted to brain surgery procedures. ROSA™ has been approved in Europe, the United States and Canada.
In 2013, MEDTECH received the “European Company of the Year Award” in the “robotic neurosurgery” category from Frost & Sullivan.
In July 2014, MEDTECH obtained the CE marking for its new product ROSA™ Spine, a robotic- assistive device for minimally invasive surgery of the spine.
In October 2014, MEDTECH won the ”Révélation” prize in the Mediterranean Deloitte Technology Fast 50 Awards.
In 2015 MEDTECH received the “2016 Company of the Year Award” in the “ robotic neurosurgery” category from Frost & Sullivan.
Communiqués au titre de l'obligation d'information permanente :
- Autres communiqués
Full and original press release in PDF:
Si le fichier PDF ne s'affiche pas ou pour le télécharger, cliquez ici.
Pour consulter le fichier PDF en intégralité, cliquez ici.
|MEDTECH||Euronext Paris||50.00 (c)||0.00%||0|